Yoga: Applying yoga for one hour a week for eight weeks to an adolescent with type 1 diabetes
Mindfulness: Applying mindfulness for one hour a week for eight weeks to an adolescent with type 1 diabetes
Study summary
The study will examine the effects of Mindfulness-Based Stress Reduction Program and yoga on stress level, quality of life and glycemic control in Youth with Type 1 diabetes.
Eligibility
Sex
ALL
Min age
13 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Youth with Type 1 diabetes between the ages of 13 and 18 with a diabetes age of at least 12 months
* Not having participated in a Mindfulness-Based Stress Reduction Program or doing yoga before,
* Speaking and understanding Turkish,
* Able to read and write,
* Having no other physiological or psychological diseases,
* No mental disability,
* Not using psychoactive drugs,
* Parents volunteered for their child to participate in the research and signed the consent form,
* During the application phase, you should have eaten 1.5-2 hours before the application and your blood sugar should be between 150-200mg/dl before the application
Exclusion Criteria:
* Failed to complete the program
* Youth diagnosed with acute or chronic diseases in addition to diabetes during the study
Primary outcome measure(s)
10-item version of the Diabetes Stress Questionnaire for Youths with Type 1 Diabetes — 8 weeks use the scale with patients 12 and up and we administer it via online survey (Qualtrics). Scores vary from 0 (not at all) to 3 (very much), so the min score=0, and the max score=30. We use the clinical cut off of 12 (scores \>=12 are flagged).
pediatrics quality of life inventoryTM (PedsQL) diabetes module 3.0 for Turkish adolescents with type 1 diabetes scale — 8 weeks The 28-item multidimensional PedsQLTM 3.0 Diabetes Module included five subscales, which are diabetes symptoms (11 items), treatment barriers (4 items), treatment adherence (7 items), worry (3 items), and communication (3 items). The format
Glycemic control form — 12 weeks it is an assessment tool developed to evaulate the hemoglobin A1C
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.